Home / Products & Pipeline
Medicines for cancer and critical care
Our portfolio addresses areas of high clinical need, with a strategic focus on oncology and hospital-based critical care.
Therapeutic areas
Our areas of focus
Oncology
A comprehensive range of oncology therapies in oral solid and sterile injectable dosage forms.
Critical care
Essential sterile injectables for hospital and intensive-care settings.
Infusion therapy
Intravenous fluids and infusion therapies supporting routine and acute hospital care.
Biologics
Biological therapies for serious, chronic and life-threatening conditions.
Diagnostics
Point-of-care diagnostic solutions that support timely clinical decision-making.
Our products are in development and are not yet approved for sale. Availability will depend on regulatory approval in each country.
Our portfolio strategy
Clinical relevance
We prioritise essential therapies for which reliable, uninterrupted supply is critical to patient care.
Quality without compromise
Every product is developed and manufactured in accordance with international regulatory standards.
Access and affordability
Local manufacturing strengthens supply security and improves the affordability of treatment.
Request product information
Detailed product information is available to healthcare partners on request.